A preventive colonoscopy can begin with a zero-dollar Medicare cost and end with coinsurance if the doctor removes tissue. Medicare’s current rule says an assigned screening costs nothing, but finding and removing a polyp or other tissue creates 15% coinsurance for the provider’s services and, in an outpatient facility, another 15% facility coinsurance. The Part B deductible does not apply, yet the unexpected percentage can still produce a real bill.
The procedure changes financially when tissue is removed
The Medicare coverage page says Part B covers screening colonoscopies with no minimum age requirement. When the provider accepts assignment, the patient pays nothing for the screening, including a follow-up colonoscopy after a positive Medicare-covered stool or blood-based biomarker screening test.
If the clinician finds and removes a polyp or other tissue, the patient owes 15% of the Medicare-approved amount for the provider’s services. At a hospital outpatient department or ambulatory surgical center, Medicare also lists 15% facility coinsurance. That second percentage applies to a separate approved facility amount, so it should not be assumed to duplicate the doctor’s exact dollar charge.
Free retirement updates: Social Security, Medicare, and retirement rules are easier to use when the fine print is translated. The free Retirement Shield newsletter does that a couple of times a week. Subscribe free.
Assignment and facility type shape the final bill
Assignment means the provider agrees to accept Medicare’s approved amount as full payment for covered services, apart from required cost sharing. Medicare’s assignment guidance explains why asking whether the doctor accepts assignment matters before the procedure. A provider who does not can create different billing consequences within Medicare rules.
The location can matter as much as the physician. A hospital outpatient department and an ambulatory surgical center can each bill a facility component, while an office setting may have a different structure. The patient should ask for the site’s name and billing type, not just the street address, because a clinic located near a hospital may still bill as a hospital department.
Medigap, retiree coverage, Medicaid or other secondary insurance may pay some or all of the 15% amounts. A Medicare Advantage plan follows its own network and cost-sharing terms while covering the required benefit. The federal percentage describes Original Medicare; the member’s plan documents control what supplemental coverage does next.
Screening frequency remains part of coverage
Medicare generally covers a screening colonoscopy once every 24 months for someone at high risk for colorectal cancer. For a person not at high risk, the interval is generally 120 months, or 48 months after a previous flexible sigmoidoscopy. A doctor may recommend an earlier procedure for clinical reasons, but the timing can affect how Medicare classifies and pays the service.
A diagnostic colonoscopy ordered for symptoms is not the same as a preventive screening. The no-cost screening rule should not be assumed when the procedure begins as diagnostic care. The ordering doctor’s documentation, prior screening result and billing codes all contribute to the claim’s classification.
Medicare’s procedure price lookup can provide estimates for outpatient procedures, but it cannot predict whether a polyp will be found. Calling both the provider and facility before the appointment can establish the approved setting and likely charges if tissue removal occurs.
A billing dispute begins with the Medicare Summary Notice
The Medicare Summary Notice shows how the claim was coded, the approved amount and the patient responsibility. A bill should be compared with that notice rather than paid from an invoice alone. If the provider billed a screening differently or charged more than the notice permits, the billing office can review the codes and documentation.
Patients should not ask a doctor to avoid medically necessary removal merely to preserve a zero-dollar screening. Removing a polyp can prevent cancer or permit diagnosis. The financial preparation is to understand that treatment during the screening can activate coinsurance and to know what secondary coverage will pay.
Prior authorization can matter in a Medicare Advantage plan even when Original Medicare would cover the procedure under its standard rules. The member should confirm the gastroenterologist, anesthesiologist and facility are in network and ask whether a positive stool test changes the authorization. A network facility does not guarantee that every professional involved is contracted under every plan.
Anesthesia and pathology can create additional claim lines. Tissue removal may lead to laboratory analysis, and sedation services can be billed by a separate clinician. The 15% rule stated by Medicare addresses the provider and facility amounts described on its screening page; a pre-procedure estimate should ask how all expected claim components will appear.
Preventive care should not be postponed solely because the exact charge is unknown. A written estimate, secondary-insurance check and payment-plan question can make a possible balance manageable. Hospitals also have financial-assistance policies, while ambulatory centers may offer different arrangements. Comparing the site before scheduling can reduce cost without changing the medical purpose of the screening.
Medicare’s current language is unusually specific: nothing is owed for an assigned screening, while removal of a polyp or other tissue produces 15% provider coinsurance and potentially a separate 15% facility share. The Part B deductible stays waived. Asking about assignment, site of service and supplemental coverage before the appointment turns that rule from a surprise bill into a budgeted possibility.
This article was produced with AI assistance and reviewed by a human editor. Figures are linked to their primary sources; where a claim could not be verified from the public record, we say so.
More Financial Reading
